I am a leader in the Payer-Provider practice, with expertise in a variety of functions and subject areas. Functionally, have focused on corporate strategy (Enterprise strategy, M&A, divestitures), growth/scaling, and large-scale cost transformation. Have focused on topics of value-based care (especially senior-focused primary care and home health), Medicare Advantage growth / profitability, and optimization of Commercial health plans.

-Interpret medical images from all modalities and perform image-guided procedures-Heavily involved in clinical and cost-effectiveness, and clinical operations projects/research

-Pre- and post-operative care of surgical patients in outpatient and inpatient setting-Completion of inpatient and outpatient surgical cases

• Selected for participation through Kellogg’s selective Venture Capital Lab Course• Evaluated the commercial potential and strategic fit of potential investments through participation in investor pitches, expert interviews and scientific research• Working with a multidisciplinary team of functional experts, authored investment proposals and final due diligence for multimillion dollar venture investments for approval by the senior leadership and investment committee of Abbott Laboratories

• Worked with a team of five MBA students to advise a multibillion dollar health system on the commercial expansion of bundled care offerings• Engaged senior human resources & benefits of large self-insured firms to determine interest and requisite features in the evaluation of a bundled payment provider partner• Analyzed provider data to identify new conditions to which bundled payments could be applied and to determine pricing for potential new offerings

Worked with an interdisciplinary team to advance the commercialization of a patented medical deviceDetermined appropriate customer segment, potential market size, relevant current and future competitors, appropriate price points, requisite regulatory pathway, and strength of intellectual property independent analysis and expert interviewsCreated pitch presentation to successfully obtain funding for prototype development and testing

• Designed study protocols with cross-functional team of physicians and PhD scientists to measure therapeutic nanoparticle delivery with MRI. Protocols were employed in subsequent projects by other lab members• Led team of animal technologists and students to complete experimental protocols and created models for analyzing MRI data and animal tissue, completing more animal experiments than any previous summer student• Presented feasibility of non-invasive drug delivery measurement at the Society of Interventional Radiology’s national scientific meeting, receiving award for outstanding medical student project• Authored two peer-reviewed journal articles related to team’s advances in the fields of local drug delivery and non-invasive drug delivery measurement.

• Led strategic SWOT analysis on an early-stage medical device and its competitors to determine the device’s market potential and subsequent commercialization strategy• Collaborated with interdisciplinary team of undergraduate and graduate students to analyze medical device’s patentability and to identify potential licensees• Presented findings and recommended commercialization strategy to senior executives of medical device firms and the Mayo Clinic Office of Intellectual Property

Studied the effects of urea on nucleic acid stability. Wrote Unix computer code for molecular dynamics simulations and performed vapor pressure osmometry. Carried out extensive data analysis and gave oral and poster presentations.Work resulted in national meeting presentation and peer-reviewed publication.